Evolent Health Inc. (NYSE:EVH) fell 2.9% during trading on Thursday . The company traded as low as $23.47 and last traded at $23.48, with a volume of 158,450 shares changing hands. The stock had previously closed at $24.18.

A number of brokerages recently commented on EVH. Jefferies Group began coverage on Evolent Health in a research report on Tuesday, July 26th. They issued a “buy” rating and a $28.00 target price on the stock. Leerink Swann reiterated an “outperform” rating and issued a $20.00 target price on shares of Evolent Health in a research report on Sunday, July 17th. Canaccord Genuity reiterated a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a research report on Wednesday, July 13th. FBR & Co upped their target price on Evolent Health from $16.00 to $24.00 and gave the company an “outperform” rating in a research report on Wednesday, July 13th. Finally, Zacks Investment Research upgraded Evolent Health from a “sell” rating to a “hold” rating in a research report on Wednesday, May 18th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. Evolent Health has a consensus rating of “Buy” and a consensus target price of $22.17.

The company has a market cap of $1.44 billion and a price-to-earnings ratio of 6.38. The company has a 50 day moving average of $20.51 and a 200-day moving average of $13.78.

Evolent Health (NYSE:EVH) last issued its earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.04. The business had revenue of $56.50 million for the quarter, compared to analyst estimates of $51.96 million. Equities research analysts forecast that Evolent Health Inc. will post ($0.62) earnings per share for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group raised its stake in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned 0.60% of Evolent Health worth $4,310,000 as of its most recent filing with the SEC.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.